for cancer, immune and metabolic disorders Developing safer and more effective solutions Advancing cellular immunotherapy to stimulate self-healing Restoring cellular homeostasis by balancing cellular metabolism Modulating tissue microenvironments to enhance therapeutic efficacy
Celloram-Logo-white

$1M

FOUNDING ROUND

Completed in 2018

$8M

SEED ROUND

Completed in 2020

FUNDING INVESTORS

MedPacto, Theragen Etex and the other key venture capital groups

HEADQUARTER

University Circle, Cleveland, OH

CELLULAR
IMMUNOTHERAPY

Immunotherapies utilizing patient’s own dendritic cells

SMALL
MOLECULES

Novel inhibitors developed as targeted therapy

DISEASE
TARGET

Cancer, Autoimmune and Metabolic Disorders